Analysts Anticipate CME Group (CME) Will Post Earnings of $1.68 Per Share

Equities research analysts expect CME Group (NASDAQ:CME) to post $1.68 earnings per share for the current quarter, Zacks reports. Three analysts have made estimates for CME Group’s earnings, with the lowest EPS estimate coming in at $1.61 and the highest estimate coming in at $1.79. CME Group reported earnings per share of $1.23 in the same quarter last year, which would suggest a positive year over year growth rate of 36.6%. The company is scheduled to report its next quarterly earnings report on Tuesday, August 7th.

According to Zacks, analysts expect that CME Group will report full year earnings of $6.79 per share for the current financial year, with EPS estimates ranging from $6.60 to $6.96. For the next year, analysts forecast that the firm will post earnings of $6.99 per share, with EPS estimates ranging from $6.85 to $7.25. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that cover CME Group.

CME Group (NASDAQ:CME) last released its earnings results on Thursday, April 26th. The financial services provider reported $1.86 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.85 by $0.01. The firm had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.12 billion. CME Group had a return on equity of 8.48% and a net margin of 111.45%. The company’s revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.22 EPS.

Several equities analysts recently commented on CME shares. Berenberg Bank began coverage on CME Group in a research report on Thursday, January 25th. They set a “hold” rating and a $170.00 target price for the company. Citigroup reissued a “buy” rating and issued a $172.00 target price (up from $155.00) on shares of CME Group in a research note on Monday, January 29th. Sandler O’Neill reissued a “buy” rating and issued a $175.00 target price on shares of CME Group in a research note on Friday, February 2nd. Barclays lifted their target price on CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Finally, Bank of America lifted their target price on CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research note on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $165.57.

Shares of CME stock opened at $159.78 on Thursday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $54.24 billion, a price-to-earnings ratio of 33.50, a PEG ratio of 2.24 and a beta of 0.57. CME Group has a 12 month low of $115.43 and a 12 month high of $171.71.

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 25th. Shareholders of record on Friday, June 8th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date of this dividend is Thursday, June 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.

In other news, insider Hilda Harris Piell sold 3,299 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $163.52, for a total value of $539,452.48. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction that occurred on Tuesday, April 10th. The shares were sold at an average price of $161.02, for a total value of $402,550.00. Following the completion of the transaction, the chief financial officer now directly owns 34,957 shares in the company, valued at approximately $5,628,776.14. The disclosure for this sale can be found here. 0.57% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the company. Ontario Teachers Pension Plan Board grew its position in shares of CME Group by 12.4% in the fourth quarter. Ontario Teachers Pension Plan Board now owns 81,393 shares of the financial services provider’s stock valued at $11,887,000 after purchasing an additional 8,991 shares during the last quarter. Honeywell International Inc. bought a new stake in shares of CME Group in the fourth quarter valued at approximately $35,052,000. LPL Financial LLC boosted its stake in shares of CME Group by 9.0% in the fourth quarter. LPL Financial LLC now owns 22,193 shares of the financial services provider’s stock valued at $3,241,000 after buying an additional 1,841 shares during the period. Capital Advisors Inc. OK boosted its stake in shares of CME Group by 5.5% in the fourth quarter. Capital Advisors Inc. OK now owns 88,822 shares of the financial services provider’s stock valued at $12,972,000 after buying an additional 4,592 shares during the period. Finally, Viking Fund Management LLC boosted its stake in shares of CME Group by 4.3% in the fourth quarter. Viking Fund Management LLC now owns 29,200 shares of the financial services provider’s stock valued at $4,265,000 after buying an additional 1,200 shares during the period. 83.10% of the stock is currently owned by institutional investors.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply